GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » LMF Acquisition Opportunities Inc (NAS:LMAOW) » Definitions » Insider Ownership

LMAOW (LMF Acquisition Opportunities) Insider Ownership : 0.00 % (As of Dec. 01, 2024)


View and export this data going back to 2021. Start your Free Trial

What is LMF Acquisition Opportunities Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, LMF Acquisition Opportunities's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, LMF Acquisition Opportunities's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, LMF Acquisition Opportunities's Float Percentage Of Total Shares Outstanding is N/A.

LMF Acquisition Opportunities Insider Ownership Historical Data

The historical data trend for LMF Acquisition Opportunities's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LMF Acquisition Opportunities Insider Ownership Chart

LMF Acquisition Opportunities Annual Data
Trend Dec20 Dec21
Insider Ownership
- -

LMF Acquisition Opportunities Quarterly Data
Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Insider Ownership Get a 7-Day Free Trial - - - - -

LMF Acquisition Opportunities Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

LMF Acquisition Opportunities Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » LMF Acquisition Opportunities Inc (NAS:LMAOW) » Definitions » Insider Ownership
Comparable Companies
ENCP FXCO VSAC EUCR OTRA OTEC AEHA AOGO GLEE JMAC GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
1200 Platt Street, Suite 1000, Tampa, FL, USA, 33602
Website
https://www.lmfacquisitions.com
LMF Acquisition Opportunities Inc is a blank check company.

LMF Acquisition Opportunities Headlines

From GuruFocus

SeaStar Medical Reports First Successful Treatment of Pediatric Patient with Hemophagocytic Lymphohistiocytosis (HLH) and Multi-Organ Failure with its SCD

By PurpleRose PurpleRose • 08-01-2022

LMF Acquisition Opportunities, Inc. Stockholders Approve Previously Announced Business Combination with SeaStar Medical, Inc.

By Value_Insider Value_Insider • 10-18-2022

SeaStar Medical Announces Publication of Clinical Trial Results Demonstrating its SCD Significantly Lowered Mortality Rates among Critically Ill ICU COVID-19 Patients by Safely and Effectively Stopping Inflammation Causing Cytokine Storms

By GuruFocusNews GuruFocusNews • 06-17-2022

SeaStar Medical Appoints Kevin Chung, MD as Chief Medical Officer

By GuruFocusNews GuruFocusNews • 06-23-2022

SeaStar Medical Appoints Kevin Chung, MD as Chief Medical Officer

By GuruFocusNews GuruFocusNews • 06-13-2022

SeaStar Medical Announces Publication of Clinical Trial Results Demonstrating its SCD Significantly Lowered Mortality Rates among Critically Ill ICU COVID-19 Patients by Safely and Effectively Stopping Inflammation Causing Cytokine Storms

By GuruFocusNews GuruFocusNews • 06-27-2022

SeaStar Medical Appoints Kevin Chung, MD as Chief Medical Officer

By GuruFocusNews GuruFocusNews • 06-03-2022

SeaStar Medical Appoints Kevin Chung, MD as Chief Medical Officer

By GuruFocusNews GuruFocusNews • 07-03-2022

LMF Acquisition Opportunities, Inc. Announces Extension of Deadline to Complete Business Combination

By PurpleRose PurpleRose • 07-29-2022

SeaStar Medical Announces Publication of Clinical Trial Results Demonstrating its SCD Significantly Lowered Mortality Rates among Critically Ill ICU COVID-19 Patients by Safely and Effectively Stopping Inflammation Causing Cytokine Storms

By GuruFocusNews GuruFocusNews • 07-07-2022